BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20605361)

  • 1. The matrix metalloproteinase-7 polymorphism rs10895304 is associated with increased recurrence risk in patients with clinically localized prostate cancer.
    Jaboin JJ; Hwang M; Lopater Z; Chen H; Ray GL; Perez C; Cai Q; Wills ML; Lu B
    Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1330-5. PubMed ID: 20605361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EGFR polymorphism rs884419 is associated with freedom from recurrence in patients with resected prostate cancer.
    Perez CA; Chen H; Shyr Y; Courtney R; Zheng W; Cai Q; Hwang M; Jaboin J; Schleicher S; Moretti L; Wills M; Smith JA; Lu B
    J Urol; 2010 May; 183(5):2062-9. PubMed ID: 20303520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of prostate cancer susceptibility variants on prostate-specific antigen recurrence after radical prostatectomy.
    Huang SP; Huang LC; Ting WC; Chen LM; Chang TY; Lu TL; Lan YH; Liu CC; Yang WH; Lee HZ; Hsieh CJ; Bao BY
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):3068-74. PubMed ID: 19900942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic predisposition to early recurrence in clinically localized prostate cancer.
    Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
    BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of cytokine gene polymorphisms on prostate-specific antigen recurrence in prostate cancer after radical prostatectomy.
    Lin HC; Liu CC; Kang WY; Yu CC; Wu TT; Wang JS; Wu WJ; Huang CH; Wu MT; Huang SP
    Urol Int; 2009; 83(4):463-70. PubMed ID: 19996656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter clinical validation of PITX2 methylation as a prostate specific antigen recurrence predictor in patients with post-radical prostatectomy prostate cancer.
    Bañez LL; Sun L; van Leenders GJ; Wheeler TM; Bangma CH; Freedland SJ; Ittmann MM; Lark AL; Madden JF; Hartman A; Weiss G; Castaños-Vélez E
    J Urol; 2010 Jul; 184(1):149-56. PubMed ID: 20478579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic significance of cyclin D1 polymorphisms on prostate-specific antigen recurrence after radical prostatectomy.
    Yu CC; Lin VC; Huang CY; Liu CC; Wang JS; Wu TT; Pu YS; Huang CH; Huang CN; Huang SP; Bao BY
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S492-9. PubMed ID: 23354566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No evidence for association of the MDM2-309 T/G promoter polymorphism with prostate cancer outcomes.
    Jaboin JJ; Hwang M; Perez CA; Cooper C; Chen H; Ye C; Cai Q; Wills ML; Lu B
    Urol Oncol; 2011; 29(3):319-23. PubMed ID: 19523862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.
    Kupelian PA; Katcher J; Levin HS; Klein EA
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1043-52. PubMed ID: 9169811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved prediction of biochemical recurrence after radical prostatectomy by genetic polymorphisms.
    Morote J; Del Amo J; Borque A; Ars E; Hernández C; Herranz F; Arruza A; Llarena R; Planas J; Viso MJ; Palou J; Raventós CX; Tejedor D; Artieda M; Simón L; Martínez A; Rioja LA
    J Urol; 2010 Aug; 184(2):506-11. PubMed ID: 20620409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: Analysis of 359 cases with a median follow-up period of 26 months.
    Abdel Raheem A; Chang KD; Alenzi MJ; Ham WS; Han WK; Choi YD; Rha KH
    Int J Urol; 2018 Dec; 25(12):1006-1014. PubMed ID: 30276864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of microvessel density in predicting recurrence in pathologic Stage T3 prostatic adenocarcinoma.
    Gettman MT; Pacelli A; Slezak J; Bergstralh EJ; Blute M; Zincke H; Bostwick DG
    Urology; 1999 Sep; 54(3):479-85. PubMed ID: 10475358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial prostate cancer: a different disease?
    Kupelian PA; Klein EA; Witte JS; Kupelian VA; Suh JH
    J Urol; 1997 Dec; 158(6):2197-201. PubMed ID: 9366343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens.
    Swindle P; Eastham JA; Ohori M; Kattan MW; Wheeler T; Maru N; Slawin K; Scardino PT
    J Urol; 2005 Sep; 174(3):903-7. PubMed ID: 16093984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radial distance of extraprostatic extension measured by ocular micrometer is an independent predictor of prostate-specific antigen recurrence: A new proposal for the substaging of pT3a prostate cancer.
    Sung MT; Lin H; Koch MO; Davidson DD; Cheng L
    Am J Surg Pathol; 2007 Feb; 31(2):311-8. PubMed ID: 17255778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association analysis of Wnt pathway genes on prostate-specific antigen recurrence after radical prostatectomy.
    Huang SP; Ting WC; Chen LM; Huang LC; Liu CC; Chen CW; Hsieh CJ; Yang WH; Chang TY; Lee HZ; Bao BY
    Ann Surg Oncol; 2010 Jan; 17(1):312-22. PubMed ID: 19777185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide detection of allelic genetic variation to predict biochemical recurrence after radical prostatectomy among prostate cancer patients using an exome SNP chip.
    Oh JJ; Park S; Lee SE; Hong SK; Lee S; Lee HM; Lee JK; Ho JN; Yoon S; Byun SS
    J Cancer Res Clin Oncol; 2015 Aug; 141(8):1493-501. PubMed ID: 25764380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Stem Cell Gene Variants Predict Disease Recurrence in Patients Treated with Radical Prostatectomy for Prostate Cancer.
    Lin VC; Huang SP; Huang CY; Yu CC; Yin HL; Huang TY; Lee CH; Lu TL; Bao BY
    Int J Med Sci; 2017; 14(12):1301-1306. PubMed ID: 29104488
    [No Abstract]   [Full Text] [Related]  

  • 20. Perineural invasion detection in prostate biopsy is related to recurrence-free survival in patients submitted to radical prostatectomy.
    Katz B; Srougi M; Dall'Oglio M; Nesrallah AJ; Sant'anna AC; Pontes J; Antunes AA; Reis ST; Viana N; Sañudo A; Camara-Lopes LH; Leite KR
    Urol Oncol; 2013 Feb; 31(2):175-9. PubMed ID: 21795075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.